NCT00474513View on ClinicalTrials.gov

An Imaging Study to Investigate the Distribution of GSK239512 in the Brain.

PHASE1CompletedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Mild Cognitive ImpairmentDementia

Interventions

DRUG

GSK239512

Trial Locations (1)

M5T 1R8

GSK Investigational Site, Toronto

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY